This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Peptron Co., Ltd., Daewoong Pharmaceutical Co., Ltd.. Active years: 2015-2018.
Company Filing History:
2 out of 5 
1 out of 77 
Years Active: 2015-2018
Title: Mi-Young Baek: Innovator in Controlled-Release Drug Delivery Systems
Introduction
Mi-Young Baek is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly in the development of controlled-release microspheres. With a total of two patents to his name, Baek's work focuses on enhancing the efficacy and safety of drug administration.
Latest Patents
Baek's latest patents include a process for preparing microspheres for sustained release that have improved dispersibility and syringeability. This innovative process involves using spray drying to create sustained release microspheres containing a biodegradable polymer and a drug. The method ensures high drug encapsulation efficiency while minimizing toxicity issues related to residual solvents. The microspheres are designed to release an effective concentration of the drug over a predetermined period, making them valuable for treating various diseases.
Another notable patent is for a controlled-release composition and microsphere for exendin, which is an active ingredient. This invention includes a biodegradable polymer and coating materials that enhance bioavailability and provide sustained release without an excessive initial burst of the active ingredient. The preparation method involves mixing exendin with a biodegradable polymer and solvent, followed by the formation of hardened microspheres and a coating layer.
Career Highlights
Throughout his career, Mi-Young Baek has worked with reputable companies such as Peptron Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.
Collaborations
Baek has collaborated with notable colleagues, including Hee-Yong Lee and Eun-Young Seol, who have supported his research and development efforts in the field of controlled-release drug delivery.
Conclusion
Mi-Young Baek's innovative work in the development of controlled-release microspheres has the potential to significantly impact the pharmaceutical industry. His patents reflect a commitment to improving drug delivery methods, ultimately enhancing patient care and treatment outcomes.